Price
Frequently asked questions
What is 10X Genomics's market capitalization?
What is the Earnings Per Share (EPS) for 10X Genomics?
What are the analyst ratings and target price for 10X Genomics's stock?
What is 10X Genomics's revenue over the trailing twelve months?
What is the EBITDA for 10X Genomics?
What is the free cash flow of 10X Genomics?
What is the 5-year beta of 10X Genomics's stock?
How many employees does 10X Genomics have, and what sector and industry does it belong to?
What is the free float of 10X Genomics's shares?
Financials
Market Cap
$1.61B5Y beta
1.82EPS (TTM)
-$1.527Free Float
103.97MRevenue (TTM)
$629.74MEBITDA (TTM)
-$134.78MFree Cashflow (TTM)
$25.04MPricing
Analyst Ratings
The price target is $39.23 and the stock is covered by 15 analysts.
Buy
8
Hold
6
Sell
1
Information
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.
1,259
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker